Loading clinical trials...

Database for Interstitial Lung Disease | Clinical Trials | Clareo Health

RECRUITING

Database for Interstitial Lung Disease

Clinical Database for the Early Recognition of Pulmonary Parenchymal Involvement in Patients With Systemic Diseases Bearing a Risk for Interstitial Lung Disease

NCT04707781•Medical University of Graz

View on ClinicalTrials.gov

Summary

The purpose of this study is to establish a clinical database for patients bearing at risk for ILD (Interstitial Lung Disease) and to set up a prospective ILD Screening program for these patients.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Age: ≥ 18 years
•patients with a known systemic disease bearing a risk for ILD
•signed informed consent (for prospective part)

Exclusion Criteria

•Age \< 18 years
•comorbidities severely limiting life-expectancy (e.g. severe cardiovascular conditions, malignant disease)

Locations (1)

Medical University of Graz, Department of Internal Medicine, Division of Pulmonology

Graz, Austria

Key Dates

Start Date

May 1, 2021

Primary Completion Date

January 31, 2029

Completion Date

January 31, 2029

Last Updated

January 15, 2026

Enrollment

412

ESTIMATED participants

Conditions

Lung Diseases, Interstitial

Interventions

chest CT

DIAGNOSTIC_TEST

Contacts

Gabor Kovacs, MD

CONTACT

+43-316-385 gabor.kovacs@klinikum-graz.at

A Randomised Clinical Trial of a Digital Self-management Package for People With Interstitial Lung Disease

NCT06122233

Lung Diseases, InterstitialPulmonary Fibrosis

View study

RECRUITINGNA

NIVATS Versus IGAVATS: a Pilot Trial Addressing Biopsy Quality in Undetermined Interstitial Lung Diseases

NCT05722340

Lung Diseases, Interstitial

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 15, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Database for Interstitial Lung Disease

Inclusion Criteria

Exclusion Criteria

A Randomised Clinical Trial of a Digital Self-management Package for People With Interstitial Lung Disease

NIVATS Versus IGAVATS: a Pilot Trial Addressing Biopsy Quality in Undetermined Interstitial Lung Diseases

Post-marketing Surveillance on Long Term Use of Ofev Capsules in Systemic Scleroderma Associated Interstitial Lung Disease (SSc-ILD) in Japan

A Study to Evaluate Long-term Safety of Nintedanib in Children and Adolescents With Interstitial Lung Disease (InPedILD®-ON)

Exercise Performance on Ambient Air vs. Low-Flow Oxygen Therapy With Chronic Lung Diseases

Identification of Novel Markers of Human Lung Disease